# Xylocaine

NDC: 0404-9972
Generic name: Lidocaine Hydrochloride and epinephrine
Labeler / Manufacturer: Henry Schein, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Marketing started: 20220110

FDA application: NDA006488

## Active ingredients

- EPINEPHRINE BITARTRATE: .005 mg/mL
- LIDOCAINE HYDROCHLORIDE ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0404-9972"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0404-9972
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfcc8a07-b40c-476d-9a21-83487318ac85